CGRP Inhibitors in Migraine
Oct 05, 2026
CGRP Inhibitors in Migraine: The Breakthrough Class Rewriting How the World Treats Its Most Disabling Headache Disorder
Summary Migraine affects approximately one in seven people globally and remains underdiagnosed and undertreated. Migraine care has shifted from repurposed drugs such as antihypertensives, antidepressants, and anticonvulsants toward mechanism-specific therapies targeting the CGRP pathway. Unlike triptans, ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
